期刊文献+

食管癌适形调强放疗病人预后多因素回归分析及其预测模型构建 被引量:2

Multivariate regression analysis of the prognosis of esophageal cancer patients with intensity modulated radiotherapy and its prediction model construction
在线阅读 下载PDF
导出
摘要 目的:探究食管癌适形调强放疗病人预后的影响因素,并根据可能影响因素构建可预测病人预后的Nomogram模型。方法:回顾性分析2012年9月至2015年10月接受适形调强放疗的80例食管癌病人。采用Kaplan-Meier法计算食管癌病人1、2、3、5年生存率,以Log Rank法行单因素预后分析,以Cox法多因素分析筛选影响病人生存的独立因素,并利用R软件建立Nomogram预测模型。结果:病人随访中位时间是36个月,1、2、3、5年生存率依次为72.50%、61.25%、53.75%和22.50%。单因素分析显示,肿瘤长度、T分期、N分期、TNM分期、化疗应用、大体肿瘤体积(GTV)、单个或多发病灶、放疗剂量与病人适形调强放疗预后有关(P<0.05~P<0.01);Cox多因素分析显示,N分期、化疗应用、放疗剂量、GTV是影响食管癌适形调强放疗预后的独立预测因素(P<0.01)。获得Nomogram预测模型的一致性指数C-index为0.746(95%CI:0.633~0.895)。结论:N分期、化疗应用、放疗剂量、GTV是影响食管癌适形调强放疗病人预后的独立影响因素,基于以上结果构建的Nomogram模型预测食管癌病人预后的效果良好。 Objective:To investigate the prognostic factors of intensity modulated radiotherapy(IMRT) in esophagus cancer,and construct a Nomogram model to predict the prognosis of patients.Methods:The clinical data of 80 esophageal cancer patients treated with IMRT from September 2012 to October 2015 were retrospectively analyzed.The Kaplan-Meier method was used to calculate the 1-year,2-year,3-year and 5-year survival rates of esophageal cancer patients,the Log Rank method was used to perform univariate prognostic analysis,the Cox method was used to screen the independent factors affecting survival,and the R software was used to establish a Nomogram prediction model.Results:The median time of follow-up was 36 months.The 1-year,2-year,3-year and 5-year survival rates were 72.50%,61.25%,53.75% and 22.50%,respectively.The results of univariate analysis showed that the tumor length,T stage,N stage,TNM stage,chemotherapy application,gross tumor volume(GTV),single or multiple lesions,radiotherapy dose were related to the prognosis of patients with IMRT(P<0.05 to P<0.01).The results of Cox multivariate analysis showed that the N stage,chemotherapy application,radiotherapy dose and GTV were the independent predictors of the prognosis of esophageal cancer(P<0.01).The C-index of this Nomogram prediction model was 0.746(95%CI:0.633-0.895).Conclusions:The N stage,chemotherapy application,radiotherapy dose and GTV are the independent factors of influencing the prognosis of patients with esophageal cancer,and this Nomogram model based on the above results can well predict the prognosis of patients with esophageal cancer.
作者 黄磊 程东苗 吴迪 张正情 郭远见 HUANG Lei;CHENG Dong-miao;WU Di;ZHANG Zheng-qing;GUO Yuan-jian(Department of Tumor Radiotherapy,Huainan First People′s Hospital,Huainan Anhui 232000,China)
出处 《蚌埠医学院学报》 CAS 2022年第8期1030-1033,1037,共5页 Journal of Bengbu Medical College
关键词 食管肿瘤 适形调强放疗 预后 多因素 预测模型 esophagus neoplasms intensity modulated radiotherapy prognosis multi-factor prediction model
  • 相关文献

参考文献8

二级参考文献61

  • 1刘向明,马明全.食管癌分子靶向治疗的新进展[J].国际生物医学工程杂志,2018,41(6):549-555. 被引量:13
  • 2祝淑钗,李任,王玉祥,李娟,邱嵘.500例中晚期食管癌单纯放疗的多因素分析[J].中华放射肿瘤学杂志,2005,14(4):253-258. 被引量:68
  • 3蔺强,高献书,乔学英,周志国,张钧,杨香然,万欣.食管癌同期放化疗PF方案剂量递增试验[J].中华放射肿瘤学杂志,2006,15(4):301-304. 被引量:24
  • 4ZhangJ, Peng F, Li N, et al. Salvage concurrent radio-chemotherapy for postoperative local recurrence of squamous-cell esophageal cancer[J]. Radiat Oncol,2012, 7(3): 93.
  • 5Eisenhauer EA, Therasse P, BogaertsJ, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.ll[J]. EurJ Cancer,2009,45(2) :228-247.
  • 6Yamamoto S, Ishihara R, Motoori M, et al. Comparison between definitive chemoradiotherapy and esophagectomy in patients with clinical stage I esophageal squamous cell carcinoma[J]. AmJ Gastroenterol, 2011, 106(6) :1048-1054.
  • 7Kato K, Tahara Mv Hironaka Svet al. A phase II study of paclitaxel by weekly I-h infusion for advanced or recurrent esophageal cancer in patients who had previously received platinum-based chemotherapy[J]. Cancer Chemother Pharmacol . 2011,67 (6): 1265-1272.
  • 8LuJC, Tao H .Chen zz.? al. Prognostic factors of radiotherapy in patients with node-positive thoracic esophageal squamous cell carcinoma after radical surgery[J]. Dis Esophagus, 2009,22 (6) : 490-495.
  • 9Ma DY, Tan BX,Liu M,et al. Concurrent three-dimensional conformal radiotherapy and chemotherapy for postoperative recurrence of mediastinal lymph node metastases in patients with esophageal squamous cell carcinoma: a phase 2 single-institution study[J]. Radiat Oncol,2014,9(6) :28.
  • 10LuJC,Kong C, Tao H. Radiotherapy with or without concurrent chemotherapy for lymph node recurrence after radical surgery of thoracic esophageal squamous cell carcinoma[J]. IntJ Radiat Oncol Bioi Phys,2010, 78(3) : 710-714.

共引文献139

同被引文献18

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部